Article
Effect of Cetuximab-Conjugated Gold Nanoparticles on the Cytotoxicity and Phenotypic Evolution of Colorectal Cancer Cells.
Molecules (Basel, Switzerland) - 22 Jan 2021
El Hallal Ralph, Lyu Nana, Wang Yuling
Abstract excerpt
Epidermal growth factor receptor (EGFR) is estimated to be overexpressed in 60~80% of colorectal cancer (CRC), which is associated with a poor prognosis. Anti-EGFR targeted monoclonal antibodies (cetuximab and panitumumab) have played an important role in the treatment of metastatic CRC. However, the therapeutic response of anti-EGFR monoclonal antibodies is limited due to multiple resistance mechanisms. With the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
